Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01774786
Brief Title: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer (JACOB)

First Submitted : January 21, 2013
First Submitted that Met QC Criteria : January 21, 2013
First Posted : January 24, 2013 (Estimate)

Results First Submitted : December 8, 2017
Results First Submitted that Met QC Criteria : January 17, 2018
Results First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : July 2, 2019
Last Update Posted : July 16, 2019